Related Experiment Video
Updated: Feb 16, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with
Charles E Rutter1, Kimberly L Johung1, Xiaopan Yao2
1Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06510, USA.
Background:
Metastatic melanoma often involves the brain. Radiotherapy is an important treatment of melanoma brain metastases, although melanoma radiosensitivity is considered heterogeneous. Thus, identifying subsets with differential radiosensitivity is essential.
Materials And Methods:
Patients with metastatic melanoma were identified in a prospective stereotactic radiosurgery (SRS) database. Tumor were tested for alterations in B-RAF, N-RAS, and c-KIT. Standardized imaging following SRS was reviewed for recurrence. Differences in local and distant failure were determined using modified Cox proportional hazards models.
Results:
102 patients and 1,028 brain metastases were included. N-RAS mutated patients were significantly less likely to develop local recurrence after SRS than wild type patients (HR 0.17, 95% CI 0.04-0.72, p=0.017). B-RAF and c-KIT mutations were not associated with altered rates of local recurrence. Lower local recurrence rates for N-RAS mutated tumors persisted on multivariate analysis (HR 0.18, 95% CI 0.04-0.84p=0.029).
Conclusions:
N-RAS mutation is associated with improved local control following SRS. Local recurrence is more common in wild type patients and those with B-RAF or c-KIT mutations. Further research is needed to validate these findings and integrate into practice.
Insights
N-RAS mutations improve local control for melanoma brain metastases treated with stereotactic radiosurgery (SRS). Wild-type and B-RAF/c-KIT mutated tumors show higher recurrence rates, guiding personalized radiotherapy.
Area of Science:
- Neuro-oncology
- Radiation Oncology
- Medical Genetics
Background:
- Metastatic melanoma frequently affects the brain, necessitating effective radiotherapy.
- Melanoma brain metastases exhibit heterogeneous radiosensitivity, requiring identification of predictive subsets.
- Stereotactic radiosurgery (SRS) is a key treatment, but outcomes vary.
Purpose of the Study:
- To investigate the association between specific gene mutations (B-RAF, N-RAS, c-KIT) and local tumor control after SRS for melanoma brain metastases.
- To identify patient subsets with differential radiosensitivity to optimize radiotherapy strategies.
Main Methods:
- Analysis of a prospective SRS database for patients with metastatic melanoma.
- Genetic testing of tumors for B-RAF, N-RAS, and c-KIT alterations.
- Review of post-SRS imaging to assess tumor recurrence and statistical modeling (Cox proportional hazards) to determine failure rates.
Main Results:
- 102 patients and 1,028 brain metastases were analyzed.
- N-RAS mutated tumors showed significantly lower local recurrence rates post-SRS compared to wild-type (HR 0.17, p=0.017).
- B-RAF and c-KIT mutations were not significantly associated with local recurrence rates; N-RAS benefit persisted in multivariate analysis (HR 0.18, p=0.029).
Conclusions:
- N-RAS mutation status is a significant predictor of improved local control following SRS for melanoma brain metastases.
- Wild-type and B-RAF/c-KIT mutated tumors are associated with higher rates of local recurrence.
- These findings suggest potential for integrating genetic markers into treatment decisions for melanoma brain metastases.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms
Point and Frameshift Mutations

